Pharmaceutical Outsourcing: A Russell Publishing Publication

Flash Advertisement 3080

White Papers

32 Results

Page 1 of 3 >>

A Blueprint for Clinical/ Commercial Convergence
Acute Kidney Injury (AKI) Biomarker Plan
Challenging the Drug Development Blueprint: A Formulator’s Perspective
Preparing for Mandatory Electronic Submission of Drug Establishment Registration and Drug Listing Information
Risk Evaluation and Mitigation Strategies (REMS) Under FDAAA
The Regulatory Paradox of Laboratory Developed Tests
Pediatric Exclusivity and Drug Development Requirements in the Overall Pediatric Population
Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development AMRI to Receive Milestone Payment from Licensing Agreement
Choosing A Supplier for Temperature-Sensitive Investigational Medicines
Validation of a Sensitive Assay to Quantify the Biomarker Cortisol in Human Saliva Utilizing HPLC with Tandem Mass Spectrometric Detection
Validation of a Sensitive LC-MS/MS Assay to Quantify the Biomarker Cyclic Guanosine Monophosphate in Human Plasma Containing Aprotinin
Lifecycle Management of Leachable Compounds in an Inhalation Product Using an Extractable Database
Management of Leachable Compounds Throughout the Lifecycle of an Inhalation Product Utilizing Statistical Experimental Designs and a Component Product Database
Assessing Extractables and Leachables from Coated Bromo-Butyl Rubber Stoppers
Establish Container Closure and Leachable Controls - A lifecycle Container Closure Database

Page 1 of 3 >>